Gluten intolerance (coeliac disease)

Area of Science:

• Immunology
• Gastroenterology
• Pathology

Background:

• Coeliac disease is a permanent gluten intolerance causing jejunal mucosal changes.
• Prevalence varies by age and sex, with a reported rate of 1 in 1637 in Edinburgh and the Lothians.
• Evidence suggests an immunologic basis, with animal models showing similar pathological features.

Purpose of the Study:

• To explore the immunologic basis of coeliac disease.
• To investigate the role of cell-mediated immunity (CMI) versus antibodies in coeliac disease pathogenesis.
• To identify potential new therapeutic targets by understanding immunoregulatory mechanisms.

Main Methods:

• Review of existing evidence on coeliac disease and related immunological reactions.
• Comparison of pathological features in animal models of intestinal T cell-mediated reactions with coeliac disease.
• Analysis of antigliadin antibody findings in various patient groups and healthy individuals.

Main Results:

• Animal models exhibit villus/crypt architectural changes, crypt hyperplasia, and increased intraepithelial lymphocytes, mirroring coeliac disease.
• CMI reactions influence goblet cell differentiation and Ia antigen expression in experimental models.
• Antigliadin antibodies are found in normal individuals and patients with other gastrointestinal conditions, suggesting limited diagnostic specificity.

Conclusions:

• Cell-mediated immune responses are likely more relevant than antibodies in coeliac disease pathogenesis.
• A failure in normal immune response inhibition to food antigens in the gut is hypothesized.
• Modulating immunoregulatory mechanisms presents a promising avenue for treating coeliac disease and other food-sensitive enteropathies.